FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283521796> ?p ?o ?g. }

• W4283521796 endingPage "101292" @default.
• W4283521796 startingPage "101292" @default.
• W4283521796 abstract "Patients with established atherosclerotic cardiovascular disease (ASCVD) need long-term antiplatelet therapy to decrease the risk of future ASCVD events. We searched PubMed, Cochrane Library, and ClinicalTrials.gov (inception through September 2021) for randomized controlled trials (RCTs) evaluating P2Y12 inhibitors vs aspirin for secondary prevention of ASCVD events. Seven RCTs including a total of 56,982 patients were included in this analysis. The median follow-up duration was 22.8 (IQR 12) months. When P2Y12 inhibitors were compared with aspirin as long-term antiplatelet therapy for secondary prevention of ASCVD events, there was a significant decrease in the risk of myocardial infarction [RR: 0.83; 95% CI: 0.72-0.94], and stroke [RR: 0.90; 95% CI: 0.83-0.99]. However, there was no significant difference in all-cause mortality [RR: 1.02; 95% CI: 0.92-1.12], or cardiovascular mortality [RR: 0.95; 95% CI: 0.83-1.08] between P2Y12 inhibitors and aspirin users. Additionally, there was no significant difference in major bleeding events [RR: 0.88; 95% CI: 0.74-1.04], or all bleeding events [RR: 1.09; 95% CI: 0.90-1.33] between P2Y12 inhibitors and aspirin groups. Use of P2Y12 inhibitor monotherapy is associated with lower rates of myocardial infarction and stroke in ASCVD patients without any significant difference in mortality, or bleeding compared to aspirin monotherapy." @default.
• W4283521796 created "2022-06-27" @default.
• W4283521796 creator A5007236274 @default.
• W4283521796 creator A5007252141 @default.
• W4283521796 creator A5010666224 @default.
• W4283521796 creator A5014036218 @default.
• W4283521796 creator A5016962694 @default.
• W4283521796 creator A5031222669 @default.
• W4283521796 creator A5036283255 @default.
• W4283521796 creator A5038949823 @default.
• W4283521796 creator A5039892440 @default.
• W4283521796 creator A5046027273 @default.
• W4283521796 creator A5059097167 @default.
• W4283521796 creator A5073224177 @default.
• W4283521796 creator A5082550796 @default.
• W4283521796 date "2022-10-01" @default.
• W4283521796 modified "2023-09-26" @default.
• W4283521796 title "P2Y12 Inhibitors versus Aspirin Monotherapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Disease Events: A Systematic Review and Meta-analysis" @default.
• W4283521796 cites W1969290517 @default.
• W4283521796 cites W1977268756 @default.
• W4283521796 cites W1977798561 @default.
• W4283521796 cites W1980150519 @default.
• W4283521796 cites W2005501262 @default.
• W4283521796 cites W2058186429 @default.
• W4283521796 cites W2064296154 @default.
• W4283521796 cites W2098923148 @default.
• W4283521796 cites W2100089051 @default.
• W4283521796 cites W2126180059 @default.
• W4283521796 cites W2131701504 @default.
• W4283521796 cites W2170062988 @default.
• W4283521796 cites W2232993138 @default.
• W4283521796 cites W2361921955 @default.
• W4283521796 cites W2799346198 @default.
• W4283521796 cites W2800245419 @default.
• W4283521796 cites W2888458270 @default.
• W4283521796 cites W2916912835 @default.
• W4283521796 cites W2947795294 @default.
• W4283521796 cites W2970684805 @default.
• W4283521796 cites W2980621175 @default.
• W4283521796 cites W3023873851 @default.
• W4283521796 cites W311320695 @default.
• W4283521796 cites W3163845177 @default.
• W4283521796 cites W3164908038 @default.
• W4283521796 cites W3176743315 @default.
• W4283521796 doi "https://doi.org/10.1016/j.cpcardiol.2022.101292" @default.
• W4283521796 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35764143" @default.
• W4283521796 hasPublicationYear "2022" @default.
• W4283521796 type Work @default.
• W4283521796 citedByCount "6" @default.
• W4283521796 countsByYear W42835217962023 @default.
• W4283521796 crossrefType "journal-article" @default.
• W4283521796 hasAuthorship W4283521796A5007236274 @default.
• W4283521796 hasAuthorship W4283521796A5007252141 @default.
• W4283521796 hasAuthorship W4283521796A5010666224 @default.
• W4283521796 hasAuthorship W4283521796A5014036218 @default.
• W4283521796 hasAuthorship W4283521796A5016962694 @default.
• W4283521796 hasAuthorship W4283521796A5031222669 @default.
• W4283521796 hasAuthorship W4283521796A5036283255 @default.
• W4283521796 hasAuthorship W4283521796A5038949823 @default.
• W4283521796 hasAuthorship W4283521796A5039892440 @default.
• W4283521796 hasAuthorship W4283521796A5046027273 @default.
• W4283521796 hasAuthorship W4283521796A5059097167 @default.
• W4283521796 hasAuthorship W4283521796A5073224177 @default.
• W4283521796 hasAuthorship W4283521796A5082550796 @default.
• W4283521796 hasConcept C126322002 @default.
• W4283521796 hasConcept C127413603 @default.
• W4283521796 hasConcept C168563851 @default.
• W4283521796 hasConcept C2776478404 @default.
• W4283521796 hasConcept C2777628954 @default.
• W4283521796 hasConcept C2777849778 @default.
• W4283521796 hasConcept C2780645631 @default.
• W4283521796 hasConcept C44249647 @default.
• W4283521796 hasConcept C49059817 @default.
• W4283521796 hasConcept C500558357 @default.
• W4283521796 hasConcept C71924100 @default.
• W4283521796 hasConcept C78519656 @default.
• W4283521796 hasConcept C82789193 @default.
• W4283521796 hasConcept C95190672 @default.
• W4283521796 hasConceptScore W4283521796C126322002 @default.
• W4283521796 hasConceptScore W4283521796C127413603 @default.
• W4283521796 hasConceptScore W4283521796C168563851 @default.
• W4283521796 hasConceptScore W4283521796C2776478404 @default.
• W4283521796 hasConceptScore W4283521796C2777628954 @default.
• W4283521796 hasConceptScore W4283521796C2777849778 @default.
• W4283521796 hasConceptScore W4283521796C2780645631 @default.
• W4283521796 hasConceptScore W4283521796C44249647 @default.
• W4283521796 hasConceptScore W4283521796C49059817 @default.
• W4283521796 hasConceptScore W4283521796C500558357 @default.
• W4283521796 hasConceptScore W4283521796C71924100 @default.
• W4283521796 hasConceptScore W4283521796C78519656 @default.
• W4283521796 hasConceptScore W4283521796C82789193 @default.
• W4283521796 hasConceptScore W4283521796C95190672 @default.
• W4283521796 hasIssue "10" @default.
• W4283521796 hasLocation W42835217961 @default.
• W4283521796 hasLocation W42835217962 @default.
• W4283521796 hasOpenAccess W4283521796 @default.
• W4283521796 hasPrimaryLocation W42835217961 @default.
• W4283521796 hasRelatedWork W2094000083 @default.

• next